𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9000 ORAL Epidermal Growth Factor Receptor (EGFR) Expression as a Predictive Biomarker of Survival in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving First-Line Therapy With Cetuximab Combined With Chemotherapy in the FLEX Trial

✍ Scribed by O'Bvrne, K.; Paz-Ares, L.; Pereira, J.R.; von Pawel, J.; Ramlau, R.; Störkel, S.; Schumacher, K.M.; von Heydebreck, A.; Celik, I.; Pirker, R.


Book ID
123397657
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
43 KB
Volume
47
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES